Literature DB >> 19833127

Forebrain overexpression of alpha-synuclein leads to early postnatal hippocampal neuron loss and synaptic disruption.

Youngshin Lim1, Vicky M Kehm, Chi Li, John Q Trojanowski, Virginia M-Y Lee.   

Abstract

Transgenic (Tg) mouse models of Parkinson's disease (PD) generated to date have primarily been designed to overexpress human alpha-synuclein (alpha-syn) to recapitulate PD-like motor impairments as well as PD-like nigrostriatal degeneration and alpha-syn pathology. However, cognitive impairments and cortical alpha-syn pathology are also common in PD patients. To model these features of PD, we created forebrain-specific conditional Tg mice that overexpress human wild type (WT) or A53T mutant alpha-syn. Here we show that both WT and A53T mutant alpha-syn lead to massive degeneration of postmitotic neurons in the hippocampal dentate gyrus (DG) during postnatal development, with hippocampal synapse loss as evidenced by reduced levels of pre- and postsynaptic markers. However, when mutant and WT alpha-syn expression was repressed until the Tg mice were mature postnatally and then induced for several months, no hippocampal neuron loss was observed. These data imply that developing neurons are more vulnerable to degenerate than mature neurons as a consequence of forebrain WT and mutant alpha-syn overexpression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19833127      PMCID: PMC2812632          DOI: 10.1016/j.expneurol.2009.10.005

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  48 in total

1.  Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.

Authors:  M Gossen; H Bujard
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

2.  Characterization of a novel protein regulated during the critical period for song learning in the zebra finch.

Authors:  J M George; H Jin; W S Woods; D F Clayton
Journal:  Neuron       Date:  1995-08       Impact factor: 17.173

3.  Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease.

Authors:  R Krüger; W Kuhn; T Müller; D Woitalla; M Graeber; S Kösel; H Przuntek; J T Epplen; L Schöls; O Riess
Journal:  Nat Genet       Date:  1998-02       Impact factor: 38.330

4.  Alpha-synuclein in Lewy bodies.

Authors:  M G Spillantini; M L Schmidt; V M Lee; J Q Trojanowski; R Jakes; M Goedert
Journal:  Nature       Date:  1997-08-28       Impact factor: 49.962

5.  Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.

Authors:  M H Polymeropoulos; C Lavedan; E Leroy; S E Ide; A Dehejia; A Dutra; B Pike; H Root; J Rubenstein; R Boyer; E S Stenroos; S Chandrasekharappa; A Athanassiadou; T Papapetropoulos; W G Johnson; A M Lazzarini; R C Duvoisin; G Di Iorio; L I Golbe; R L Nussbaum
Journal:  Science       Date:  1997-06-27       Impact factor: 47.728

6.  Mutant and wild type human alpha-synucleins assemble into elongated filaments with distinct morphologies in vitro.

Authors:  B I Giasson; K Uryu; J Q Trojanowski; V M Lee
Journal:  J Biol Chem       Date:  1999-03-19       Impact factor: 5.157

7.  Control of memory formation through regulated expression of a CaMKII transgene.

Authors:  M Mayford; M E Bach; Y Y Huang; L Wang; R D Hawkins; E R Kandel
Journal:  Science       Date:  1996-12-06       Impact factor: 47.728

8.  Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease.

Authors:  K A Conway; J D Harper; P T Lansbury
Journal:  Nat Med       Date:  1998-11       Impact factor: 53.440

9.  Antecedent clinical features associated with dementia in Parkinson's disease.

Authors:  Y Stern; K Marder; M X Tang; R Mayeux
Journal:  Neurology       Date:  1993-09       Impact factor: 9.910

10.  Cognitive impairments in different stages of Parkinson's disease.

Authors:  S E Starkstein; P L Bolduc; T J Preziosi; R G Robinson
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1989       Impact factor: 2.198

View more
  16 in total

1.  α-Syn suppression reverses synaptic and memory defects in a mouse model of dementia with Lewy bodies.

Authors:  Youngshin Lim; Victoria M Kehm; Edward B Lee; James H Soper; Chi Li; John Q Trojanowski; Virginia M-Y Lee
Journal:  J Neurosci       Date:  2011-07-06       Impact factor: 6.167

2.  Selective lowering of synapsins induced by oligomeric α-synuclein exacerbates memory deficits.

Authors:  Megan E Larson; Susan J Greimel; Fatou Amar; Michael LaCroix; Gabriel Boyle; Mathew A Sherman; Hallie Schley; Camille Miel; Julie A Schneider; Rakez Kayed; Fabio Benfenati; Michael K Lee; David A Bennett; Sylvain E Lesné
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-22       Impact factor: 11.205

3.  A progressive dopaminergic phenotype associated with neurotoxic conversion of α-synuclein in BAC-transgenic rats.

Authors:  Silke Nuber; Florian Harmuth; Zacharias Kohl; Anthony Adame; Margaritha Trejo; Kai Schönig; Frank Zimmermann; Claudia Bauer; Nicolas Casadei; Christiane Giel; Carsten Calaminus; Bernd J Pichler; Poul H Jensen; Christian P Müller; Davide Amato; Johannes Kornhuber; Peter Teismann; Hodaka Yamakado; Ryosuke Takahashi; Juergen Winkler; Eliezer Masliah; Olaf Riess
Journal:  Brain       Date:  2013-02       Impact factor: 13.501

4.  Prion infection promotes extensive accumulation of α-synuclein in aged human α-synuclein transgenic mice.

Authors:  Eliezer Masliah; Edward Rockenstein; Chandra Inglis; Anthony Adame; Cyrus Bett; Melanie Lucero; Christina J Sigurdson
Journal:  Prion       Date:  2012-04-01       Impact factor: 3.931

Review 5.  Animal models of α-synucleinopathy for Parkinson disease drug development.

Authors:  James B Koprich; Lorraine V Kalia; Jonathan M Brotchie
Journal:  Nat Rev Neurosci       Date:  2017-07-13       Impact factor: 34.870

6.  TDP-43 expression influences amyloidβ plaque deposition and tau aggregation.

Authors:  Stephani A Davis; Kok Ann Gan; James A Dowell; Nigel J Cairns; Michael A Gitcho
Journal:  Neurobiol Dis       Date:  2017-04-20       Impact factor: 5.996

Review 7.  [Cellular replacement strategies and adult neurogenesis in idiopathic Parkinson's disease].

Authors:  F Marxreiter; A Storch; J Winkler
Journal:  Nervenarzt       Date:  2016-08       Impact factor: 1.214

8.  Dysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice.

Authors:  Lionel M Igaz; Linda K Kwong; Edward B Lee; Alice Chen-Plotkin; Eric Swanson; Travis Unger; Joe Malunda; Yan Xu; Matthew J Winton; John Q Trojanowski; Virginia M-Y Lee
Journal:  J Clin Invest       Date:  2011-01-04       Impact factor: 14.808

Review 9.  Parkinson's disease mouse models in translational research.

Authors:  Paul M A Antony; Nico J Diederich; Rudi Balling
Journal:  Mamm Genome       Date:  2011-05-11       Impact factor: 2.957

10.  Combinational losses of synucleins reveal their differential requirements for compensating age-dependent alterations in motor behavior and dopamine metabolism.

Authors:  Natalie Connor-Robson; Owen M Peters; Steven Millership; Natalia Ninkina; Vladimir L Buchman
Journal:  Neurobiol Aging       Date:  2016-07-04       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.